InvestorsHub Logo

4running

11/16/20 11:35 AM

#30616 RE: mantis #30607

its a safe drug that has been tested for safety and shows preliminarily tremendous efficacy. They announced manufacturing partners and objectives for distribution. They also have the science and management team behind them and trade at less than 40c. The question should be why arent more people eager to buy and why so inexpensive.

Plus covid is likely a small part of the role this will play in lung lining protection.